|
"liu c j"的相關文件
顯示項目 1106-1115 / 1268 (共127頁)
<< < 106 107 108 109 110 111 112 113 114 115 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T07:39:34Z |
Minimal role of GB virus-C/hepatitis G virus in fulminant and subfulminant hepatitis in Taiwan
|
Liu, C.-J.; Kao, J.-H.; Lai, M.-Y.; Chen, P.-J.; Chu, J.-S.; Chen, W.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:35Z |
Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection
|
Hsu, C.-S.;Liu, C.-H.;Liu, C.-J.;Wang, C.-C.;Chen, C.-L.;Lai, M.-Y.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:33Z |
Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C
|
Hsieh, T.-H.;Tseng, T.-C.;Liu, C.-J.;Lai, M.-Y.;Chen, P.-J.;Hsieh, H.-L.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:35:31Z |
Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy
|
Liu, C.-H.;Liang, C.-C.;Liu, C.-J.;Tsai, H.-B.;Hung, P.-H.;Hsu, S.-J.;Chen, S.-L.;Lin, J.-W.;Lai, M.-Y.;Chen, J.-H.;Chen, P.-J.;Chen, D.-S.;Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:11:03Z |
Temporal relationship between hepatitis B virus enhancer II/basal core promoter sequence variation and risk of hepatocellular carcinoma
|
Chou, Y.-C.;Yu, M.-W.;Wu, C.-F.;Yang, S.-Y.;Lin, C.-L.;Liu, C.-J.;Shin, W.-L.;Chen, P.-J.;Liaw, Y.-F.;Chen, C.-J.; MING-WHEI YU; Chou, YC; CHUN-JEN LIU; Yu, MW; Wu, CF; Yang, SY; Lin, CL; Liu, CJ; Shih, WL; Chen, PJ; Liaw, YF; Chen, CJ. |
| 臺大學術典藏 |
2018-09-10T07:06:31Z |
Genetic variability of hepatitis B virus and response to antiviral therapy
|
Liu, C.-J.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:30Z |
Core promoter mutations of hepatitis B virus and hepatocellular carcinoma: Story beyond A1762T/G1764A mutations
|
Liu, C.-J.;Kao, J.-H.; CHUN-JEN LIU; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:27Z |
Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis
|
Wang, C.-C.;Hsu, C.-S.;Liu, C.-J.;Kao, J.-H.;Chen, D.-S.; Wang, CC; CHUN-JEN LIU; DING-SHINN CHEN; Hsu, CS; Liu, CJ; JIA-HORNG KAO; Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T07:06:11Z |
Metabolic profiles in patients with chronic hepatitis C: A case-control study
|
Hsu, C.-S.; Liu, C.-J.; Liu, C.-H.; Chen, C.-L.; Lai, M.-Y.; Chen, P.-J.; Chen, D.-S.; Kao, J.-H.; CHUN-JEN LIU; PEI-JER CHEN; CHEN-HUA LIU; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T07:06:09Z |
A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients
|
Tseng, T.-C.; Liu, C.-J.; Wang, C.-C.; Chen, P.-J.; Lai, M.-Y.; Kao, J.-H.; Chen, D.-S.; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
顯示項目 1106-1115 / 1268 (共127頁)
<< < 106 107 108 109 110 111 112 113 114 115 > >>
每頁顯示[10|25|50]項目
|
